‘No change’ in risk profile with second blood clot case linked to AstraZeneca Two cases of clotting in 700,000 administered doses does not indicate an increased level of risk, experts have said.
Broader storage conditions for Pfizer vaccine bring GPs into the fold TGA-approved guideline changes have opened the possibility for general practices to take part in the rollout of the mRNA vaccine.
Changes to the vaccine rollout: What are the immediate impacts for GPs? Effects of Australia’s pivot from AstraZeneca to Pfizer for people under 50 are being felt as practices work to ease patient concerns.
AstraZeneca blood clot link increases importance of Novavax But with clinical trials progressing slowly, uncertainty remains over when Australia will access the 51 million doses of its third vaccine candidate.
Media fails to cover harms of early diagnostic testing: study Researchers fear a lack of risk–benefit analysis may be contributing to overdiagnosis.
ATAGI issues GPs with guidance for clotting condition ‘likely’ linked to COVID vaccine The national advisory body is urging vaccine providers to be aware of post-vaccination warning signs, including new onset of severe persistent headache that is not settling with analgesia.
GPs ‘in the dark’ over aged care vaccination delays Failure to reach vaccination targets and a lack of communication has left GPs concerned and unable to prepare for the influenza vaccine rollout.
Guidelines questioned as research highlights COVID aerosol threat Coughing can create 100 times more aerosol particles than oxygen therapies, increasing risk for healthcare workers who wear surgical masks.
GPs need ‘complete predictability on supply’: Calls for better communication amid vaccine delays Lagging deliveries have forced some GPs to be creative in securing vaccines for their patients.
Lockdowns to be ‘part of the Australian way of life’ until everyone is vaccinated Greater Brisbane’s three-day snap lockdown has added further pressure to overstretched general practices already navigating a backlog of health concerns and the COVID vaccine rollout.